Cardiovascular System Clinical Trial
— VASSTOfficial title:
Vascular Adaptations to Single-Sprint Training
Verified date | May 2024 |
Source | University of Mississippi, Oxford |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The long-term objective of this research line is to identify and implement an effective and feasible intervention capable of preventing and/or reducing the burden of cardiometabolic and obesity-related diseases that affect Mississippians and others. The pursuit of this long-term objective will begin with achieving the specific aims proposed in this pilot project, which are to determine the effect of single sprint training for improving (1) systemic macro-vascular function, (2) local and systemic micro-vascular function, and (3) cardiorespiratory fitness. These aims will be achieved using a randomized controlled trial whereby 40 males and females will be randomized into an intervention group (n=20) or time-matched negative control group (n=20). The intervention group will perform a single maximal effort sprint on a cycle ergometer for twenty seconds 3 days/week for 4 weeks and the control group will be asked to maintain pre-intervention habits/behavior over 4 weeks. All outcome measures are non-invasive, and will be assessed pre-, mid-, and post-intervention, with the exception of cardiorespiratory fitness, which will be measured pre- and post-. To achieve aim 1, brachial artery flow-mediated dilation via ultrasonography and systolic and diastolic blood pressure via automated oscillometry will be measured on the arm. To achieve aim 2, post-occlusive reactive hyperemia via near-infrared spectroscopy and reactive hyperemia via ultrasound will be measured in the arm and leg, respectively. To achieve aim 3, pulmonary gas exchange will be measured during a graded exercise test on a cycle ergometer. All outcomes will be compared across time between conditions and sex with a three-way Bayesian Repeated Measures ANOVA using pre-values as covariates and an uninformed prior. 95% credible intervals will also be calculated to power future investigations using this intervention. If the intervention is found effective, future studies will be conducted to determine the efficacy of the intervention in larger groups and more clinical populations, and to determine the mechanisms mediating the adaptations. If ineffective, the knowledge gained will be used to develop future interventions.
Status | Active, not recruiting |
Enrollment | 46 |
Est. completion date | June 4, 2024 |
Est. primary completion date | June 4, 2024 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 35 Years |
Eligibility | Inclusion Criteria: - Age 18-35 years - Untrained (no regular exercise engagement for the previous 6 months) - Healthy enough to begin exercise (assessed via Physical Activity Readiness Questionnaire) Exclusion Criteria: - Illness/injury preventing cycling exercise - Prescribed medication to control heart rate - Prescribed medication to control blood pressure - Use of nicotine within the previous 6 months |
Country | Name | City | State |
---|---|---|---|
United States | University of Mississippi | University | Mississippi |
Lead Sponsor | Collaborator |
---|---|
University of Mississippi, Oxford |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change from baseline systemic macrovascular function at 2 weeks and 4 weeks | Systemic macrovascular changes will be quantified by measuring 1) brachial artery flow-mediated dilation via vascular ultrasound, and 2) resting brachial blood pressure via a standard automated blood pressure cuff. | week 0, week 2, and week 4 | |
Primary | Change from baseline local and systemic microvascular function at 2 weeks and 4 weeks | Systemic changes in microvascular endothelial function will be quantified by using the post-occlusive reactive hyperemia technique in the arm. Local microvascular function will be measured using the passive leg movement technique for reactive hyperemia and post-occlusive reactive hyperemia in the leg. | week 0, week 2, and week 4 | |
Secondary | Change from baseline maximal oxygen consumption at 2 weeks and 4 weeks | To assess changes in cardiorespiratory fitness, pulmonary gas exchange data will be collected during a maximal graded exercise test on a cycle ergometer. VO2max and ventilation thresholds will be reported in accordance with current guidelines. | week 0, week 2, and week 4 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03697499 -
Effects of Fish Oil in Alleviating Health Hazards Associated With Ozone Exposure
|
N/A | |
Active, not recruiting |
NCT04153539 -
Acute Health Effects of Traffic-Related Air Pollution Exposure
|
N/A | |
Completed |
NCT04579497 -
Temperature-dependent Changes in Cardiovascular Parameters During Warm Water Footbaths in Healthy Women
|
N/A | |
Active, not recruiting |
NCT05575752 -
Acute Health Effects of High Temperature Exposure
|
N/A | |
Completed |
NCT02977390 -
Passive Leg Raise Induced Stroke Volume Changes in Elderly Prior to Elective Surgery Measured by LiDCOplusTM
|
N/A | |
Not yet recruiting |
NCT06076629 -
Acute Health Effects of Low Temperature Exposure
|
N/A | |
Completed |
NCT05866848 -
Effects of Caffeine on Cerebral Blood Flow
|
N/A | |
Completed |
NCT05289817 -
Effects of Transcutaneous Electrical Stimulation on the Autonomous Nerve System in Healthy Young People
|
N/A | |
Completed |
NCT04209738 -
Changes in Cardiovascular and Sleep Quality Parameters Under Eurythmy Therapy and Tai Chi in Comparison to Standard Care - A Substudy of the ENTAiER Trial
|
||
Completed |
NCT02979327 -
Cardiovascular Effects of Adderall in Healthy Adults.
|
Early Phase 1 | |
Completed |
NCT01940822 -
Cardiovascular Effects of Energy Drinks in Healthy Adults
|
N/A | |
Completed |
NCT03395977 -
Uric Acid Effects on Endothelium and Oxydative Stress
|
N/A | |
Completed |
NCT03810118 -
Fluid Challenge Infusion and Response
|
N/A |